AdipoGen Life Sciences Notch signalling research reagents
The Notch signalling pathway regulates many different cell fate decisions in both vertebrate and invertebrate species. Deregulations in Notch signalling components have been associated with various human disorders such as cancer, immune disorders, developmental syndromes, stroke and cognitive symptoms.
AdipoGen Life Sciences brings a comprehensive range of Notch signalling reagents to the market. Products include Notch receptors (Notch 1 and 2), canonical Notch ligands (DLL1, DLL3 and DLL4), non-classical Notch ligands (DLK1 and DLK2), E3 ubiquitin ligases, deubiquitinating enzymes and Notch inhibitors.
The reagents are suitable for scientists requiring tools for cancer, T cell and developmental biology research.
Phone: 02 9698 2022
Antibodies Inc Recombinant Antibodies
Recombinant chimeric antibodies are designed to offer several advantages beyond easy multiplexing.
AdipoGen Immune Checkpoint Reagents for Immuno-Oncology Research
AdipoGen Life Sciences offers a broad panel of immune checkpoint reagents, including recombinant...
AdipoGen Life Sciences Isthmin-1
AdipoGen Life Sciences' Isthmin-1 (human) ELISA Kit is designed to provide specific...
